Press Release: Rich Pharmaceuticals : Rich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML Patients

Rich Pharmaceuticals: Rich Pharmaceuticals Inc RCHA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

Rich Pharmaceuticals: RICH PHARMACEUTICALS, INC. (OTCMKTS:RCHA) Files An 8-K Entry into a Material Definitive Agreement

Rich Pharmaceuticals: Rich Pharmaceuticals Inc RCHA Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300

Press Release: Rich Pharmaceuticals : Rich Pharmaceuticals, Inc. (OTC Pink: RCHA) Jumps 25% After Study Drug RP-323 (TPA) Potential Treatment For Hodgkin's Lymphoma

Rich Pharmaceuticals: Rich Pharmaceuticals' Study Drug RP-323 (TPA) Elevates White Blood Cells (WBCs) Which Play a Vital Role Fighting Infections, and in Immunotherapy

Rich Pharmaceuticals: UPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials